Health & pharmaceuticals news

Latest breaking stories, features and analysis

Invitae to receive £830 million from SoftBank-led group of investors
  • Invitae to receive £830 million from SoftBank-led group of investors
  • The U.S. company says investment will be in senior convertible notes.
  • Invitae Corp will acquire genomics company Genosity for £144 million.
April 5, 2021

Market analysis

AstraZeneca stock price gains as Trump considers fast-tracking their COVID-19 vaccine
Shares of AstraZeneca PLC (LON: AZN) gained over 1% on reports that the U.S. government considers fast-tracking the approval for Astrazeneca’s coronavirus vaccine in the States before the forthcoming presidential elections, according to a report by the Financial Times.  Fundamental analysis: Unrealistic scenario? The FT report said that…
August 25, 2020
Bayer stock price slips after reporting a Q2 loss of $11.2 billion
Shares of Bayer AG (ETR: BAYN) slipped 4% after the German pharma giant reported a big loss in the second quarter of the year. Bayer stock price is now trading near 3-months lows.  Fundamental analysis: Roundup costs push Bayer to a loss Bayer, the German pharmaceutical and chemicals giant,…
August 4, 2020
Relief Therapeutics’ stock price explodes 90% on emergency COVID-19 treatment
Shares of Relief Therapeutics (SIX: RLF) exploded 80% on Monday after the drugmaker said its “RLF-100” treatment, developed together with the U.S.-Israeli firm NeuroRx, showed early potential. Fundamental analysis: Emergency treatment for critically ill patients NeuroRx and Relief, a Swiss-based drugmaker, issued a joint statement to note progress with…
August 3, 2020
Sanofi stock price moves higher on a £500 million vaccine deal
Shares of Sanofi (EPA: SAN) gained around 1% today after the UK government agreed to buy $500 million worth of COVID-19 vaccines from Sanofi and GlaxoSmithKline (LON: GLK). Moreover, the French giant raised its 2020 earnings forecast today.  Fundamental analysis: Earnings forecast upgraded  Sanofi, the world’s fifth-largest pharma…
July 29, 2020

More breaking stories